© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
DarioHealth Corp. (DRIO) stock declined over 0.00%, trading at $6.77 on NASDAQ, down from the previous close of $6.77. The stock opened at $6.91, fluctuating between $6.50 and $7.00 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 6.81 | 7.00 | 6.45 | 6.77 | 17.9K |
| Aug 27, 2026 | 7.08 | 7.49 | 6.77 | 6.77 | 20.12K |
| Aug 26, 2026 | 7.29 | 7.41 | 7.03 | 7.03 | 34.01K |
| Aug 25, 2026 | 7.10 | 7.72 | 6.66 | 7.39 | 123.55K |
| Aug 24, 2026 | 7.13 | 7.54 | 7.13 | 7.21 | 10.23K |
| Aug 21, 2026 | 7.25 | 8.06 | 7.10 | 7.49 | 4.84K |
| Aug 20, 2026 | 7.16 | 7.67 | 7.02 | 7.17 | 8.36K |
| Aug 19, 2026 | 7.55 | 7.87 | 7.15 | 7.16 | 31.97K |
| Aug 18, 2026 | 7.54 | 7.64 | 7.03 | 7.18 | 6.37K |
| Aug 17, 2026 | 7.61 | 7.94 | 7.29 | 7.36 | 21.91K |
| Aug 14, 2026 | 7.24 | 7.92 | 7.24 | 7.59 | 5.32K |
| Aug 13, 2026 | 7.72 | 7.94 | 7.21 | 7.33 | 9.36K |
| Aug 12, 2026 | 7.67 | 7.78 | 7.17 | 7.48 | 10.2K |
| Aug 11, 2026 | 7.34 | 8.03 | 6.75 | 7.67 | 54.98K |
| Aug 10, 2026 | 7.42 | 7.89 | 6.90 | 7.66 | 24.34K |
| Aug 07, 2026 | 7.34 | 8.20 | 7.30 | 7.30 | 29.55K |
| Aug 06, 2026 | 7.67 | 7.88 | 7.40 | 7.75 | 3.96K |
| Aug 05, 2026 | 6.98 | 7.66 | 6.70 | 7.66 | 17.01K |
| Aug 04, 2026 | 7.30 | 7.71 | 6.19 | 6.87 | 164.68K |
| Aug 03, 2026 | 7.22 | 7.52 | 6.83 | 7.10 | 9.84K |
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
| Employees | 163 |
| Beta | 1.12 |
| Sales or Revenue | $20.35M |
| 5Y Sales Change% | -0.886% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Specialties |